BioCentury | Jul 30, 2019
Financial News

June 30 Financial Quick Takes: $40M series B for Hinova; plus TriArm and PredictImmune raise rounds

...Shanghai, China) raised $20 million in a series A round led by Panacea Venture and Virtus Inspire Ventures...
BioCentury | Dec 7, 2018
Financial News

Salubris leads Viracta venture round, gets Chinese rights to cancer therapy

Shenzhen Salubris Pharmaceuticals Co. Ltd. (SZSE:002294) led a series C round for Viracta Therapeutics Inc. (San Diego, Calif.) on Dec. 4 and gained Chinese rights to develop Viracta’s nanatinostat (VRx-3996) in combination with an antiviral...
BioCentury | Dec 4, 2018
Financial News

Salubris leads Viracta venture round, gets Chinese rights to cancer therapy

Shenzhen Salubris Pharmaceuticals Co. Ltd. (SZSE:002294) led a series C round for Viracta Therapeutics Inc. (San Diego, Calif.) on Tuesday and gained Chinese rights to develop Viracta’s nanatinostat (VRx-3996) in combination with an antiviral to...
BioCentury | Aug 10, 2018
Financial News

Apexigen announces $73M in series B, C rounds

...Decheng Capital, while the $58 million series C round was led by 3E Bioventures Capital, Virtus Inspire Ventures...
BioCentury | Aug 8, 2018
Financial News

Apexigen announces $73M in series B, C rounds

...Decheng Capital, while the $58 million series C round was led by 3E Bioventures Capital, Virtus Inspire Ventures...
BioCentury | Jun 13, 2016
Financial News

Applied StemCell completes venture financing

...Date completed: 2016-06-06 Type: Venture financing Raised: $19 million Investors: HerMed Capital; Ping An Ventures; Virtus Inspire Ventures...
BioCentury | Feb 29, 2016
Financial News

Rani Therapeutics financial update

...the round to more than $50 million. New investors AstraZeneca plc (LSE:AZN; NYSE:AZN, London, U.K.); Virtus Inspire Ventures...
BioCentury | Feb 25, 2016
Financial News

Delivery play Rani tops off series C

...bringing the round's total to more than $50 million. New investors AstraZeneca plc (LSE:AZN; NYSE:AZN), Virtus Inspire Ventures...
Items per page:
1 - 8 of 8
BioCentury | Jul 30, 2019
Financial News

June 30 Financial Quick Takes: $40M series B for Hinova; plus TriArm and PredictImmune raise rounds

...Shanghai, China) raised $20 million in a series A round led by Panacea Venture and Virtus Inspire Ventures...
BioCentury | Dec 7, 2018
Financial News

Salubris leads Viracta venture round, gets Chinese rights to cancer therapy

Shenzhen Salubris Pharmaceuticals Co. Ltd. (SZSE:002294) led a series C round for Viracta Therapeutics Inc. (San Diego, Calif.) on Dec. 4 and gained Chinese rights to develop Viracta’s nanatinostat (VRx-3996) in combination with an antiviral...
BioCentury | Dec 4, 2018
Financial News

Salubris leads Viracta venture round, gets Chinese rights to cancer therapy

Shenzhen Salubris Pharmaceuticals Co. Ltd. (SZSE:002294) led a series C round for Viracta Therapeutics Inc. (San Diego, Calif.) on Tuesday and gained Chinese rights to develop Viracta’s nanatinostat (VRx-3996) in combination with an antiviral to...
BioCentury | Aug 10, 2018
Financial News

Apexigen announces $73M in series B, C rounds

...Decheng Capital, while the $58 million series C round was led by 3E Bioventures Capital, Virtus Inspire Ventures...
BioCentury | Aug 8, 2018
Financial News

Apexigen announces $73M in series B, C rounds

...Decheng Capital, while the $58 million series C round was led by 3E Bioventures Capital, Virtus Inspire Ventures...
BioCentury | Jun 13, 2016
Financial News

Applied StemCell completes venture financing

...Date completed: 2016-06-06 Type: Venture financing Raised: $19 million Investors: HerMed Capital; Ping An Ventures; Virtus Inspire Ventures...
BioCentury | Feb 29, 2016
Financial News

Rani Therapeutics financial update

...the round to more than $50 million. New investors AstraZeneca plc (LSE:AZN; NYSE:AZN, London, U.K.); Virtus Inspire Ventures...
BioCentury | Feb 25, 2016
Financial News

Delivery play Rani tops off series C

...bringing the round's total to more than $50 million. New investors AstraZeneca plc (LSE:AZN; NYSE:AZN), Virtus Inspire Ventures...
Items per page:
1 - 8 of 8